Point72 Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $94.3K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $4.75M | Sell |
|
|||||
|
2022
Q2 | $16.9M | Sell |
|
|||||
|
2022
Q1 | $49M | Sell |
|
|||||
|
2021
Q4 | $58.4M | Buy |
|
|||||
|
2021
Q3 | $30.3M | Buy |
|
|||||
|
2021
Q2 | $17M | Sell |
|
|||||
|
2021
Q1 | $63.2M | Buy |
|
|||||
|
2020
Q4 | $53.4M | Buy |
|
|||||
|
2020
Q3 | $25.6M | Buy |
|
|||||
|
2020
Q2 | $30.1M | Buy |
|
|||||
|
2020
Q1 | $12.3M | Buy |
|